TG Therapeutics (TGTX)
(Delayed Data from NSDQ)
$23.83 USD
+0.50 (2.14%)
Updated Sep 27, 2024 04:00 PM ET
After-Market: $23.82 -0.01 (-0.04%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth B Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/6/24 |
---|---|
Current Quarter | 0.03 |
EPS Last Quarter | 0.04 |
Last EPS Surprise | 200.00% |
ABR | 1.63 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 0.13 |
Next Year | 0.83 |
EPS (TTM) | 0.61 |
P/E (F1) | 189.56 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 80.30M | 97.34M | 314.58M | 494.87M |
# of Estimates | 4 | 4 | 4 | 4 |
High Estimate | 82.88M | 100.30M | 317.50M | 574.90M |
Low Estimate | 76.70M | 93.62M | 307.26M | 373.79M |
Year ago Sales | 165.82M | 43.97M | 233.66M | 314.58M |
Year over Year Growth Est. | -51.58% | 121.38% | 34.63% | 57.31% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.03 | 0.09 | 0.13 | 0.83 |
# of Estimates | 4 | 4 | 7 | 6 |
Most Recent Consensus | 0.03 | 0.10 | -0.03 | 1.02 |
High Estimate | 0.04 | 0.11 | 0.45 | 1.02 |
Low Estimate | 0.02 | 0.04 | -0.03 | 0.35 |
Year ago EPS | 0.73 | -0.09 | 0.09 | 0.13 |
Year over Year Growth Est. | -95.89% | 200.00% | 44.44% | 543.05% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 4 | 4 | 6 | 4 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.03 | 0.09 | 0.13 | 0.83 |
7 Days Ago | 0.03 | 0.09 | 0.13 | 0.83 |
30 Days Ago | 0.03 | 0.09 | 0.13 | 0.83 |
60 Days Ago | -0.01 | 0.03 | -0.01 | 0.63 |
90 Days Ago | -0.01 | 0.03 | -0.01 | 0.64 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.03 | 0.09 | 0.13 | 0.83 |
Zacks Consensus Estimate | 0.03 | 0.09 | 0.13 | 0.83 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.04 | -0.07 | -0.09 | 0.73 | NA |
Estimate | -0.04 | -0.03 | -0.12 | 0.29 | NA |
Difference | 0.08 | -0.04 | 0.03 | 0.44 | 0.13 |
Surprise | 200.00% | -133.33% | 25.00% | 151.72% | 60.85% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more